Safety of Amiodarone and Ranolazine Together in Patients With Angina
Public ClinicalTrials.gov record NCT01558830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety of Amiodarone and Ranolazine Together in Patients With Stable Angina
Study identification
- NCT ID
- NCT01558830
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Cardiovascular Consultants of Nevada
- Other
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Interventions
- ranolazine Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 35 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2011
- Primary completion
- Mar 31, 2013
- Completion
- Jun 30, 2013
- Last update posted
- Mar 20, 2012
2012 – 2013
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiovascular Consultants of Nevada | Henderson | Nevada | 89052 | Recruiting |
| Cardiovascular Consultants of Nevada | Las Vegas | Nevada | 89144 | Recruiting |
| Cardiovascular Consultants of Nevada | Las Vegas | Nevada | 89196 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01558830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2012 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01558830 live on ClinicalTrials.gov.